The role of nitric oxide in cardiac surgery

Surgery Today

Volumn 27, Issue 7, 1997, Pages 583-592

  Nonami, Yoshiki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cardiac surgery; Myocardial reperfusion injury; Nitric oxide

Indexed keywords

NITRIC OXIDE;

HEART INFARCTION; HEART PROTECTION; HEART SURGERY; HUMAN; LUNG BLOOD VESSEL; OXIDATION REDUCTION REACTION; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; VASODILATATION;

ANIMALS; ANOXEMIA; ARGININE; CARDIAC SURGICAL PROCEDURES; DISEASE MODELS, ANIMAL; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL ACTIVATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATION;

EID: 0030669563     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02388212     Document Type: Review

References (95)

1. Furchgott RF, Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018
2. Jennings RB, Reimer KA, Steenbergen C (1986) Myocardial ischemia revisited: the osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 18:769-780
3. Quillen JE, Selke FW, Brooks LA, Harrison DG (1990) Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 2:586-594
4. Johnson G, Tsao PC, Lefer AM (1991) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19:244-252
5. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM (1992) Cardioprotection of organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260:668-675
6. Lefer DJ, Nakanishi K, Johnson WE, Vinten-Johansen J (1993) Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88:2337-2350
7. Lefer DJ, Nakanishi K, Vinten-Johansen J (1993) Endothelial and myocardial cell protection by a cystein-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 22:S34-S43
8. Weyrich AS, Ma X-L, Lefer LM (1992) The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86:279-288
9. Nakanishi K, Zhao ZQ, Vinten-Johansen J, Hudspeth DA, McGee DS, Hammon JW Jr, Salem W (1995) Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 103:1146-1154
10. Nakanishi K, Vinten-Johansen J, Lefer DJ, Fowler WC, McGee DS, Johnston WE (1992) Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263:H1650-1658
11. Hiramatsu T, Forbess JM, Miura T, Mayer Jr JE (1995) Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. Evidence for an important role of endothelial production of nitric oxide. J Thorac Cardiovasc Surg 109:81-87
12. Sato H, Zhao ZQ, McGee D, Williams MW, Hammon JW, Vinten-Johansen J (1995) Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 110:302-314
13. Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub MH (1995) L-Arginine reverses low coronary reflow and enhances postisehaemic recovery of cardiac mechanical function. Cardiovasc Res 30:200-204
14. Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK (1995) Cardiopulmonary bypass, myocardial management, and support techniques. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 110:1047-1053
15. Wanna FS, Obayashi DY, Young JN, DeCampli WM (1995) Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury. J Thorac Cardiovasc Surg 110:1054-1062
16. Fukuda H, Sawa Y, Kadoba K, Taniguchi K, Shimazaki Y, Matsuda H (1995) Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 92:413-416
17. Schulz R, Wambolt R (1995) Inhibition of nitric oxide synthesis protect the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 30:432-439
18. Patel VC, Yellon DM, Singh KJ, Neild GH, Woolfson RG (1993) Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 194:234-238
19. Woolfson RG, Patel VC, Neild GH, Yellon DM (1995) Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91:1545-1551
20. Takeuchi K, McGowan FX, Danh H-C, Glynn P, Simplaceanu E, del Nido PJ (1995) Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol 27:1405-1414
21. G-nitro-L-arginine improves myocardial function following ischemia/ reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 27:419-426
22. Sellden H, Winberg P, Gustafsson L, Lundell B, Book K, Frostell C (1993) Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 78:577-580
23. Berner M, Beghetti M, Ricou B, Rouge J, Prêtre R, Friedli B (1993) Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 19:75-77
24. Haydar A, Mauriat P, Journois D, Pouard P, Safran D, Vouhé P (1992) Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 340:1545
25. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ (1994) Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 108:487-194
26. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM (1993) Inhaled nitric oxide in congenital heart disease. Circulation 87:447-453
27. Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666
28. DeBelder AJ, Radomski MW, Why HFJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S (1993) Nitric oxide synthase activities in human myocardium. Lancet 341:84-85
29. Archer S (1993) Measurement of nitric oxide in biological models. FASEB J 7:349-360
30. Moncada S (1992) The L-arginine: nitric oxide pathway. Acta Physiol Scand 145:201-227
31. Estrada Gomez C, Martin C, Mondada S, Gonzalez C (1992) Nitric oxide mediates tumor necrosis factor-alfa cytotoxicity in endothelial cells. Biochem Biophys Res Commun 186:475-482
32. Bogle RG, Baydoun AR, Pearson CD, Moncada S, Mann GE (1992) L-arginine transport is increased in macrophages generating nitric oxide. Biochem J 284:15-18
33. Bogle RG, Moncada S, Pearson CD, Mann GE (1992) Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 105:768-770
34. Flaherty JT (1989) Nitrate tolerance: A review of the evidence. Drug 37:523-550
35. Miller VM, Vanhoutte PM (1989) Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins. J Cardiovasc Pharmaeol 14:S67-S71
36. Gerzer R, Drummer C, Karrenbrock B, Heim JM (1989) Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. J Cardiovasc Pharmacol 14:S115-S119
37. Schini VB, Bond R, Gao Y, Illiano S, Junquero DC, Mombouli JV, Nagao T, Smart F, Vanhoutte M (1993) The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. J Cardiovasc Pharmacol 22:S10-S16
38. Stamler JS, Single DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902
39. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for biologic activity of endothelium derived relaxing factor. Nature 327:524-526
40. Wennmalm A, Benthin G, Petersson AS (1992) Dependence of metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106:507-508
41. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-140
42. Node K, Kitakaze M, Yokoyama H, Imai K, Komamura K, Minamino T, Kosaka H, Sato H, Tada M, Inoue M, Hori M, Kamada T (1995) Evidence for nitric oxide production from human ischemic hearts. J Mol Cell Cardiol A:159
43. Shultz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a calcium-independent nitric oxide synthase in the myocardium. Br J Pharmac 105:575-580
44. Shindo T, Ikeda U, Ohkawa F, Kawahara K, Yokoyama M, Shimada K (1995) Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 29:813-819
45. Robbins RA, Hamel FG, Floreani AA, Gossman GL, Nelson KJ, Belenky S, Rubinstein I (1993) Bovine bronchil epithelial cells metabolize L-arginine to L-citrulline: Possible role of nitric oxide synthase. Life Sci 52:709-716
46. Furlong B, Henderson AM, Lewis MJ, Smith JA (1987) Endothelium derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90:687-692
47. Sneddon JM, Vane JR (1988) Endothelium-derived relaxing factor reduce platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 85:2800-2804
48. Brady AJB, Warren JB, Poor-Wilson PA, Williams TJ, Harding AS (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-H182
49. Luscher TF, Raji L, Vanhoutte PM (1987) Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9:157-163
50. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T (1993) Role of L-arginine-nitric oxide pathway in hypertension. J Hypertens 11:639-645
51. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME (1992) Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90:1168-1172
52. Harrison DG, Freiman PG, Armstrong ML, Marcus ML, Heistad DD (1987) Alterations of vascular reactivity in atherosclerosis. Circ Res 61 [Suppl]:74-80
53. Lefer AM, Sedar AW (1991) Endothelial alterations in hypercholesterolaemia and atherosclerosis. Pharmacol Res 23:1-12
54. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation endproducts quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438
55. Chin JH, Azhar S, Hoffman BB (1992) Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 89:10-18
56. Drexler H, Hayoz D, Münzel T, Hornig B, Just H, Brunner HR, Zelis R (1992) Endothelial function in chronic congestive heart failure. Am J Cardiol 69:1596-1601
57. Archer SL, Cowan NJ (1991) Acetylcholine causes endothelium dependent vasodilation but does not stimulate nitric oxide production by rat pulmonary arteries or elevate endothelial cytosolic calcium concentrations. Circ Res 68:1569-1581
58. Martin W, Smith J, Lewis MJ, Henderson AH (1988) Evidence the inhibitory factor extracted from bovine retractor penis is nitrite, whose activated derivative is stabilized nitric oxide. Br J Pharmacol 93:579-585
59. Arroyo C, Kohno M (1991) Difficulties encountered in the detection of nitric oxide (NO) by spin trapping techniques. A cautionary note. Free Radic Res Commun 14:145-155
60. Keim M, Feelisch M, Spahr R, Piper HM, Noack E, Schrader J (1988) Quantitative and kinetic characterization of nitric oxide and EDRF release from cultured endothelial cells. Biochem Biophys Res Commun 154:237-244
61. Schmidt HHW (1995) Determination of nitric oxide via measurement of nitrite and nitrate in culture media. Biochemica 2:22
62. Pearson PJ, Schaff HV, Vanhoutte PM (1990) Acute endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 67(2):385-393
63. Hashimoto K, Pearson PJ, Schaff HV, Cartier R (1991) Endothelial cell dysfunction after ischemic arrest and reperfusion: A possible mechanism of myocardial injury during reflow. J Thorac Cardiovasc Surg 102:668-694
64. Pearson PJ, Lin PJ, Schaff HV (1992) Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. J Thorac Cardiovasc Surg 103:1147-1154
65. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM (1990) Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Ciculation 82:1402-1412
66. Inauen ME, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR (1990) Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: Role of elastase. Am J Physiol 28:H925-H931
67. Nilsson FN, Miller VM, Vanhoutte PM, McGregor CGA (1991) Methods of cardiac preservation after the function of the endothelium in porcine coronary arteries. J Thorac Cardiovasc Surg 102:923-930
68. Thompson J, Hess M (1986) The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 28:449-492
69. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
70. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, Lefer DJ (1996) Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78:65-72
71. Williams MW, Taft CS, Ramnauth S, Zhao Z-Q, Vinten-Johansen J (1995) Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 30: 79-86
72. Matheis G, Sheeman MP, Buckberg GD, Haybean DM, Young HH, Ignarro LJ (1992) Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 262:H616-H620
73. Brown JM, Grosso MA, Tarada GJ, Whitman GJ, Banerjee A, White CW, Karren AH, Repine JE (1989) Endoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat heart. Proc Natl Acad Sci USA 86:2516-2520
74. Morita K, Sherman MP, Buckberg GD, Ihnken K, Matheis G, Young HH, Ignarro LJ (1995) Studies of hypoxemic/reperfusion injury: without aortic clamping. Role of the L-arginine - nitric oxide pathway: The nitric oxide paradox. J Thorac Cardiovasc Surg 110:1200-1211
75. Massey MF, Davies MG, Svendsen E, Klyachkin ML, Barber L, Hagen P-O (1993) Ketanserin inhibits experimental vein graft intimal hyperplasia. J Surg Res 54:530-538
76. Davies MG, Kim JH, Dalen H, Makhoul RG, Svensen E, Hagen P-O (1994) Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 116:557-568
77. Guo J, Milhoan KA, Tuan RS, Lefer AM (1994) Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury. Circ Res 75:77-84
78. DeMeyer GRY, Bult H, Üstünes L, Kockx MM, Feelisch M, Herman AG (1995) Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits. J Cardiovasc Pharmacol 26:272-279
79. Rich G, Murphy G, Roos C, Johns R (1993) Inhaled nitric oxide: selective pulmonary vasodilatation in cardiac surgical patients. Anesthesiology 78:1028-1035
80. Pepke-Zaba J, Higenbottam T, Dinh-Zuan A (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-1174
81. Frostell C, Fractacci M-D, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstricton. Circulation 83:2038-2047
82. Ignarro L (1989) Biological actions and properties of endothelial-derived nitric oxide formed and released from artery and vein. Circ Res 65:1-21
83. Fratacci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75:990-999
84. Girard C, Lehot J, Pannetier J, Filley S, French P, Estanove S (1992) Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary hypertension. Anesthesiology 77:880-883
85. Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 107:1129-1135
86. Hugod C (1979) Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 42:159-167
87. Shuel FO (1967) Morbid anatomical changes in the lungs of dogs after inhalation of higher oxide of nitrogen during anesthesia. Br J Anaesth 39:413-424
88. Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistant pulmonary hypertension of the newborn. Lancet 340:819-820
89. Pearson PJ, Evora PRB, Ayrancioglu K, Schaff HV (1992) Protamine releases endothelium-derived relaxing factor from systemic arteries: a possible mechanism of hypotension during heparin neutralization. Circulation 86:289-294
90. Searle NR, Sahab P (1992) Endothelial vasomotor regulation in health and disease. Can J Anaesth 39:838-857
91. Fung HL, Chung SJ, Bauer JA (1992) Biochemical mechanism of organic nitrate action. Am J Cardiol 70:4B-10B
92. McGregor M (1982) The nitrates and myocardial ischemia. Circulation 66:689-692
93. Lichtenthal PR, Rossi EC, Louis G (1985) Dose-related prolongation of the bleeding time by intravenous nitroglycerin. Anesth Analg 64:30-33
94. Armstrong PW, Moffat JA (1983) Tolerance to organic nitrates: clinical and experimental perspectives. Am J Med 74:74-84
95. Selke FW, Tomanek RJ, Harrison DG (1991) L-Cystein selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. J Pharmacol Exp Ther 258:365-369